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Abstract
Background: Normal preimplantation embryo development encompasses a series of events including
first cleavage division, activation of the embryonic genome, compaction and blastocyst formation.
First lineage differentiation starts at the blastocyst stage with the formation of the trophectoderm and the
inner cell mass. The main objective of this study was the detection, identification and expression analysis
of genes associated with blastocyst formation in order to help us better understand this process. This
information could lead to improvements of in vitro embryo production procedures.
Results: A subtractive cDNA library was constructed enriched for transcripts preferentially expressed at
the blastocyst stage compared to the 2-cell and 8-cell stage. Sequence information was obtained for 65
randomly selected clones. The RNA expression levels of 12 candidate genes were determined throughout
3 stages of preimplantation embryo development (2-cell, 8-cell and blastocyst) and compared with the
RNA expression levels of in vivo "golden standard" embryos using real-time PCR. The RNA expression
profiles of 9 (75%) transcripts (KRT18, FN1, MYL6, ATP1B3, FTH1, HINT1, SLC25A5, ATP6V0B, RPL10) were
in agreement with the subtractive cDNA cloning approach, whereas for the remaining 3 (25%) (ACTN1,
COPE, EEF1A1) the RNA expression level was equal or even higher at the earlier developmental stages
compared to the blastocyst stage. Moreover, significant differences in RNA expression levels were
observed between in vitro and in vivo produced embryos. By immunofluorescent labelling, the protein
expression of KRT18, FN1 and MYL6 was determined throughout bovine preimplantation embryo
development and showed the same pattern as the RNA expression analyses.
Conclusion:  By subtractive cDNA cloning, candidate genes involved in blastocyst formation were
identified. For several candidate genes, important differences in gene expression were observed between
in vivo and in vitro produced embryos, reflecting the influence of the in vitro culture system on the embryonic
gene expression. Both RNA and protein expression analysis demonstrated that KRT18, FN1 and MYL6 are
differentially expressed during preimplantation embryo development and those genes can be considered
as markers for bovine blastocyst formation.
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Background
The low success rate of in vitro embryo production proce-
dures in cattle, together with early embryonic mortality,
lead to the loss of a large number of potential calves,
retarded genetic progress and consequently the loss of
money and time for the cattle breeding industry. Despite
improvements on the culture media and culture condi-
tions only 30–40% of the fertilised oocytes reach the blas-
tocyst stage and it is generally accepted that the quality
and developmental competence of in vitro produced (IVP)
bovine embryos has failed to keep up with those of their
in vivo counterparts [1].
Normal preimplantation embryo development in cattle is
characterised by several cleavage divisions of the fertilised
egg, activation of the embryonic genome around the 8–16
cell stage, compaction and blastocoel formation leading
to the blastocyst. Before the major activation of the
embryonic genome, the bovine preimplantation embryo
is controlled by maternal genomic information that is
accumulated during oogenesis [2]. Both the maternal and
embryonic gene expression occurs in a stage- and time-
dependent manner [3].
The first important differentiation events take place at the
blastocyst stage, resulting in the generation of two distinct
cell lineages: the trophectoderm cells (TE) and the inner
cell mass (ICM). The ICM gives rise to the embryo,
whereas the TE forms the placenta. Since these two line-
ages are divergent in morphological and biochemical
aspects, it is reasonable to hypothesise that many differen-
tiation-related genes are expressed at this stage. Genes
being expressed in the blastocyst stage but not in earlier
stages are therefore functional candidates for the regula-
tive processes that take place at the onset of differentiation
[4]. The identification of novel genes involved in blasto-
cyst formation and the analysis of their expression pat-
terns may help us to understand the mechanisms that
control blastocyst formation and may help us to under-
stand why certain embryos do not make it through this
stage. As in vitro culture conditions do not fully mimic the
in vivo situation and as it has been shown that morpholog-
ical and physiological differences [5-7] as well as differ-
ences in gene expression [8-11] exist between in vivo and
in vitro cultured embryos, the RNA expression levels of in
vitro produced embryos should be compared with those of
in vivo "golden standard" embryos. Changes in transcript
abundance between in vitro and in vivo embryos may help
to assess the normality of in vitro produced embryos and
may help to optimise the in vitro culture conditions.
In previous studies, genes involved in preimplantation
embryo development were identified using techniques
such as differential display reverse transcription PCR
[4,12,13], large scale cDNA library construction [14-16],
cDNA microarray [17-19] and suppression subtractive
hybridisation (SSH) [4,20-22]. Subtractive cDNA cloning
[23] is a powerful tool for the detection of stage-specific
transcribed genes. In contrast to e.g. microarray analysis,
this PCR-based method can be accomplished without
prior knowledge of the genes being expressed, and yields
subtracted cDNA pools that are differentially expressed.
However, further confirmation of the outcome is required
by means of real-time PCR, which is a perfect technique
not only to validate the subtractive cDNA cloning results,
but also to gather quantitative data concerning the
selected transcripts. In the present study subtractive cDNA
cloning was used to detect genes that are differentially
expressed in the bovine blastocyst compared to genes
present in 2-cell and 8-cell stage embryos. The differential
RNA expression status of 12 subtracted cDNA clones was
validated throughout 3 stages of preimplantation embryo
development (2-cell, 8-cell and blastocyst) and compared
with the RNA expression levels of their in vivo "golden
standard" counterparts using real-time PCR. By immun-
ofluorescent labelling, the protein expression of 3 genes
with high differences in RNA expression levels between
the developmental stages was examined during preim-
plantation embryo development to check whether the
protein expression patterns were comparable with the
RNA expression levels.
Results
Construction and screening of the SSH library
A subtractive cDNA library was constructed for the enrich-
ment of transcripts preferentially expressed in in vitro cul-
tured blastocysts relative to 2-cell and 8-cell embryos.
As bovine embryos contain limited amounts of mRNA
and as the subtractive cDNA cloning requires at least 0.5
µg of starting material, a linear amplification step was per-
formed using the SMART PCR cDNA synthesis Kit. By
using 27 PCR cycles for linear amplification, the forma-
tion of non-specific PCR products due to overcycling was
prevented.
The amplification products enriched for blastocyst spe-
cific genes were cloned, single clones were randomly
picked and single-pass sequenced. Partial sequence infor-
mation was obtained for 65 clones. Those partial
sequences were compared with known sequences in the
Genbank by doing a BLAST analysis against the mammal
nr database. BLAST searches revealed that 54 sequences
were homologous to 36 different known genes, 5
sequences were homologous to genomic sequences and 2
clones had no matches in the database and could not be
identified. The 4 remaining clones were false positives,
giving similarity with the cloning vector. Among the iden-
tified genes, we found 14 genes coding for ribosomal pro-
teins and 10 mitochondrial genes.
The sequence data of the clones were submitted to the
NCBI dbEST database [24] and the accession numbers
and their putative identities are listed in Table 1.BMC Developmental Biology 2007, 7:64 http://www.biomedcentral.com/1471-213X/7/64
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Table 1: Overview of the blastocyst specific subtracted cDNA clones compared to known sequences in Genbank
EST 
Accession 
Number
Gene name Function Accession Number 
BlastN
% Identity
DQ347577 B. taurus γ-actin Cytoplasmic 2 Cytoskeletal protein NM_001033618 99% 443/447
DQ347578 100% 237/237
DQ347579 B. taurus actinin, α 1 Cytoskeletal protein XM_591685 99% 257/258
DQ347580 B. taurus Fibronectin 1 Cytoskeletal protein XM874396 95% 457/478
DQ347581 H. sapiens Microtubule-actin crosslink factor 1 Cytoskeletal protein NM_012090 88% 425/478
DQ347582 89% 317/354
DQ347583 B. taurus Myosin light chain prot. 6 Cytoskeletal protein BTMYO217 99% 413/417
DQ347584 B. taurus cytokeratin 18 Cytoskeletal protein XM_582930 99% 442/443
DQ347585 96% 219/228
DQ347586 B. taurus Adenin nucleotide translocator 2 Transporter activity AB065433 97% 272/279
DQ347587 97% 245/259
DQ347588 99% 300/301
DQ347589 98% 297/303
DQ347590 B. taurus Ferritin heavy chain polypeptide 1 Iron storage NM_174062 98% 171/174
DQ347591 99% 230/231
DQ347592 AF540563 100% 167/167
DQ347593 100% 170/170
DQ347594 95% 356/372
DQ347595 B. taurus Histidine triad nucleotide binding protein 1 Hydrolase NM_175812 95% 350/366
DQ347596 95% 340/356
DQ347597 B. taurus coatomer protein complex, subunit ε retrograde Golgi-to-ER 
transport
X76980 99% 364/366
DQ347598 B. taurus neural precursor cell expressed, developmental 
down-regulated 8
linkage of ubiquitin AF227256 99% 173/174
DQ347599 H. sapiens tyrosine 3-monooxygenase signal transduction BC010352 91% 77/84
DQ347600 H. sapiens ATPase Na/K transporting, subunit b3 Osmoregulation NM_001035393 99% 212/214
DQ347601 98% 175/178
DQ347634 B. taurus cyclin G-associated kinase Cell cycle NM_001046084 95% 226/236
DQ347637 96% 130/135
DQ347603 B. taurus elongation factor 1 α Translation AJ238405 89% 305/341
DQ347604 B. taurus ribosomal prot. L3 Translation NM_174715 100% 167/167
DQ347605 B. taurus ribosomal prot. L6 NM_001031756 99% 133/134
DQ347606 H. sapiens ribosomal prot. L7 NM_001014928 99% 423/426
DQ347607 B. taurus ribosomal prot. L10/QM NM_174760 99% 166/167
DQ347608 B. taurus ribosomal prot. L17 AB099021 96% 256/265
DQ347609 B. taurus ribosomal prot. L23 NM_001035014 99% 330/331
DQ347610 B. taurus ribosomal prot. S5 NM_001015531 98% 465/470
DQ347611 H. sapiens ribosomal prot. S11 NM_001024568 99% 289/290
DQ347613 B. taurus ribosomal prot S8 NM_001025317 99% 333/334
DQ347612 B. taurus ribosomal prot. S12 BC102500 98% 386/390
DQ347614 B. taurus ribosomal prot. 40S S26-2-like NM_001015561 98% 331/336
DQ347615 B. taurus ribosomal prot. S27 XM_880953 99% 287/289
DQ347616 B. taurus ribosomal prot. large P2 NM_174788 98% 443/452
DQ347617 B. taurus U1 snRNP-specific prot. XM_872762 99% 331/333
DQ347602 B. taurus ATPase H+ transporter V0 subunit b Energy metabolism NM_001038038 100% 634/634
DQ347636 B. taurus cytochrome C oxidase 7A2 Energy metabolism NM_175807 94%199/210
DQ347618 B. taurus mitoch. genome ATP6 Energy metabolism AY526085 100% 251/251
DQ347619 B. taurus mitoch. genome ND4 99% 250/251
DQ347620 B. taurus mitoch. genome COX3 98% 374/381
DQ347621 B. taurus mitoch. genome COX2 99% 225/226
DQ347622 B. taurus mitoch. genome COX1 97% 260/268
DQ347623 B. taurus mitoch. genome COX3 98% 259/264
DQ347624 B. taurus mitoch. genome COX2 99% 219/220
DQ347625 B. taurus mitoch. genome COX2 99% 226/227
DQ347626 B. taurus mitoch. genome COX1 100% 240/240
DQ347627 B. taurus mitoch. genome COX2 99% 429/430
DQ347629 B. taurus BAC library clone rp42-147e22 Unknown AC092858 98% 400/406
DQ347631 95% 141/147
DQ347628 B. taurus BAC library clone rp42-518P7 Unknown AC129959 94% 218/230
DQ347630 98% 193/195
DQ347632 B. taurus BAC library clone CH240-472P12 Unknown AC150855 90% 142/157
DQ347633 Unknown EST Unknown No similarity found
DQ347635BMC Developmental Biology 2007, 7:64 http://www.biomedcentral.com/1471-213X/7/64
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Quantification of specific transcripts by real-time PCR
Real-time RT-PCR analysis was performed for 12 genes in
order to make a relative quantification of the RNA levels
in the 3 studied bovine developmental stages and to check
for differences in RNA levels between in vivo and in vitro
produced embryos.
Primers were designed for a selection of 12 identified
genes, based on their gene function. The primer informa-
tion (gene symbol, gene name, amplicon accession
number, GenBank accession number and % identities
with Genbank sequences) is listed in Table 2. Gene-spe-
cific amplification was confirmed for the 12 primer pairs
by sequencing, by a single peak in melt-curve analysis and
a single band with the expected size in agarose gel-electro-
phoresis. No primer-dimer formation was detected and
the standard curves derived from 10-fold serial dilutions
of pooled cDNA gave correlation coefficients greater than
0.99 and efficiencies between 82 and 105%. The RNA
expression levels of the selected genes were measured in
duplicate in 3 to 6 single in vitro and in vivo produced
embryos from the 3 studied stages of preimplantation
development (2-cell, 8-cell and blastocyst).
To correct for any variation in both mRNA content and
differences in enzymatic efficiencies, the quantitative
results were normalised to the geometric mean of the 3
best reference genes as described in our previous study
[25]. The normalised values for each target transcript were
analysed using the 95% confidence intervals.
The mean relative abundances of the gene transcripts
studied are shown in Figure 1.
KRT18 was not detected up to the blastocyst stage, and no
differences were observed between in vitro and in vivo pro-
duced embryos. For MYL6 and FN1 the RNA levels were
significantly higher at the blastocyst stage compared to the
earlier stages. Remarkable is the 3.5-fold higher FN1 RNA
expression in in vivo produced blastocysts compared with
their in vitro produced counterparts.
The differences between the blastocysts and the 2/8-cell
stage embryos for FTH1 were smaller but significant in
both in vitro and in vivo produced embryos.
ATP1B3, HINT1, SLC25A5, ATP6V0B and RPL10 had sig-
nificantly lower RNA levels in in vitro produced 2/8-cell
embryos compared to the in vitro produced blastocysts,
but surprisingly no significant differences exist between
the in vivo produced 8-cell and in vivo produced blastocyst
embryos. This is due to a lower RNA level in the in vivo
produced blastocysts (ATP1B3 and SLC25A5) on the one
side and a higher RNA level at the 8-cell stage (RPL10) on
the other side or a combination of both (HINT1  and
ATP6V0B).
In contrast, 3 genes (ACTN1, COPE and EEF1A1) showed
a relative expression pattern that was not in agreement
with the results obtained by SSH. The RNA levels for those
3 genes were highest at the 8-cell stage and decreased sig-
nificantly at the blastocyst stage. Especially for COPE but
also for EEF1A1 the in vivo produced 8-cell embryos had a
significantly higher RNA level than their in vitro produced
counterparts.
Immunofluorescent labelling
Immunofluorescent labelling was performed for KRT18,
FN1 and MYL6 on in vitro produced embryos of different
developmental stages (2–4 cell, 5–8 cell, morula day 5
p.i., morula day 7 p.i., blastocyst day 7 p.i. and hatched
blastocyst day 8 p.i) to verify whether the protein expres-
sion showed the same pattern as the RNA expression. The
results of the immunofluorescent labelling experiments
are shown in Figure 2.
No KRT18 expression was measured in the 2–4 cell and 5–
8 cell embryos except for a few small positive spots on the
Table 2: Details of the primers used for PCR analysis
Gene Symbol Gene Name Amplicon Acc. Number Genbank Acc. Number % Identity
ACTN1 Actinin, alpha 1 DQ347561 XM_603102 100%
ATP1B3 Na/K ATPase, beta 3 subunit DQ347562 EST SSH 100%
ATP6V0B H+ ATPase, V0 subunit B DQ347563 XM_582011 100%
COPE coatomer protein complex, subunit epsilon DQ347564 NM_176673 100%
EEF1A1 Elongation factor 1 alpha DQ347565 AJ238405 100%
FN1 Fibronectin 1 DQ347566 K00800 100%
FTH1 Ferritin heavy chain polypeptide 1 DQ347567 NM_174062 99%
HINT1 Histidine triad nucleotide binding protein 1 DQ347568 NM_175812 98%
KRT18 Cytokeratin 18 DQ347569 XM_582930 100%
MYL6 Myosin light chain protein 6 DQ347572 NM_175780 100%
RPL10 Ribosomal protein L10/QM DQ347575 NM_174760 100%
SLC25A5 Adenin nucleotide translocator 2 DQ347576 NM_174659 100%BMC Developmental Biology 2007, 7:64 http://www.biomedcentral.com/1471-213X/7/64
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surface of the embryos, which may be caused by remain-
ders of cumulus cells. The first onset of the KRT18 protein
expression was detected at the morula day 5 p.i. and at the
morula day 7 p.i. a ring of KRT18 positive cells was
observed. At the blastocyst stage, KRT18 was predomi-
nantly expressed in the TE cells, whereas little or no
expression was measured in the ICM. As shown in Figure
3A, KRT18 was detected at the cell-cell contact sites of the
TE cells.
FN1 was not detected in the first developmental stages.
The first onset of FN1 expression was seen in 7-day old
morulae and it was clearly present at the blastocyst stages.
But in contrast to KRT18, FN1 was very distinct in the
ICM, forming filamentous structures between the TE and
the ICM.
No MYL6 protein expression was seen before 7 days p.i
MYL6 was strongly expressed at the late morula, the blas-
tocyst and hatched blastocyst stage. In Figure 3B one can
appreciate that MYL6 is located in the TE cells surround-
ing the blastocoel cavity.
The images of the positive and negative control experi-
ments are supplemented in additional file 1.
The results of the immunofluorescent experiments were
consistent with the RNA expression patterns during pre-
implantation embryo development.
Discussion
In the present study a subtractive cDNA library was con-
structed between blastocyst embryos as the tester popula-
tion and a pool of 2-cell and 8-cell embryos as the driver
population, in order to enrich for genes differentially
expressed at the blastocyst stage.
Sequence information was obtained for 65 randomly
picked clones. Out of these 65 ESTs representing the blas-
tocyst embryos, 10 were homologous to mitochondrial
genes and 14 to ribosomal genes. Mitochondria play an
essential role in many events during early development.
In cattle, the mtDNA copy number increases during blast-
ocyst expansion and hatching, consistent with an increase
in mitochondrial RNAs. This indicates that the transcrip-
tional activation of the mitochondrial genome coincides
with the pronounced structural and functional differenti-
ation of the mitochondria during preimplantation devel-
opment [26]. The largest group of ESTs was identified as
genes involved in protein synthesis and included several
Results of the immunofluorescent experiments for KRT18,  FN1 and MYL6 Figure 2
Results of the immunofluorescent experiments for 
KRT18, FN1 and MYL6. Confocal laser scanning images of 
in vitro produced bovine embryos labelled with primary 
mouse antibodies for KRT18, FN1 and MYL6 respectively in 
combination with FITC-labelled secondary goat-anti-mouse 
antibodies. The nuclei are stained with propidium iodide. Dif-
ferent stages of preimplantation embryo development were 
analysed (2–4 cell, 5–8 cell, M5: morula day 5 p.i., M7: morula 
day 7 p.i., B7: blastocyst day 7 p.i., B8: blastocyst day 8 p.i.).
Comparison of the relative expression levels of 12 genes at 3  stages of bovine embryo development Figure 1
Comparison of the relative expression levels of 12 
genes at 3 stages of bovine embryo development. 
Mean relative abundance of 12 transcripts at 3 different 
developmental stages (2-cell, 8-cell and blastocyst) of in vitro 
(lilac-coloured bars)and in vivo (claret-coloured bars) pro-
duced bovine embryos, determined by real-time qPCR.
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ribosomal proteins. The high degree of ribosomal protein
mRNAs corresponds with previous data showing that
between the 2-cell stage and the blastocyst stage, the level
of ribosomal protein mRNA is said to increase about 20-
fold [27]. The protein content of in vivo derived preattach-
ment cattle embryos increases 2-fold from the 2-cell
through to the blastocyst stage [28]. This rise in protein
content is correlated with rapid cell divisions at the late
morula and early blastocyst stage [29,30].
Real-time qPCR was used to verify the SSH results and at
the same time to compare the gene expression between in
vitro  produced embryos and in vivo golden standard
embryos. The geometric mean of GAPD,  YWHAZ  and
SDHA  was used for normalisation. Vandesompele and
colleagues [31] demonstrated that the conventional use of
a single gene for normalisation leads to relative large
errors and validated the geometric mean of multiple care-
fully selected housekeeping genes as an accurate normali-
sation factor. In Goossens and colleagues [25] it was
demonstrated that GAPD, YWHAZ and SDHA were stably
expressed reference genes, suitable for normalisation of
quantitative data within different preimplantation
embryo stages. The problem of measuring RNA expres-
sion levels throughout preimplantation development is
confounded by the fact that cell numbers and cell sizes are
constantly changing during this developmental interval.
To allow ontogenic analysis, the embryos were compared
as a single unit and the reference genes will correct for the
differences between the embryos. Other normalisation
strategies, like normalisation against total cell number,
normalisation against RNA mass quantity or the use of
exogenous control RNA (spike) [32,33] are not assump-
tion free. Spikes correct for differences in RNA extraction
and differences in enzymatic efficiencies but do not
account for the quality and quantity of input sample.
In most studies about gene expression in embryos, only
the RNA expression was considered, but the differences in
RNA expression do not always imply differences on pro-
tein level, as there may be regulation at the translation
level as well. By immunofluorescent labelling using
mouse antibodies, the protein expression of KRT18, FN1
and MYL6 was evaluated for the first time during bovine
preimplantation embryo development. Furthermore, the
location of the protein expression in the embryo can tell
us more about the specific function of the protein during
the process of blastocyst formation.
Both KRT18 mRNA and protein expression were found to
be absent at the 2-cell and 8-cell stage and abundant at rel-
atively high levels at the blastocyst stage, demonstrating
the embryonic origin of this transcript. KRT18 was only
expressed in the cell-cell contact sites of the TE, but not in
those of the ICM. This makes that KRT18 can be seen as a
marker for differentiation, adding to previous described
markers for trophoblast differentiation in mice as there
are Cdx2 and Eomes [34-36]. As TE is a kind of specialized
epithelium, genes involved in de novo differentiation of
an epithelium, including gene families encoding for cell
polarity, cell junctions, cytoskelet formation and ion
transport [37,38] are involved in TE differentiation.
KRT18 is a cytoskeletal protein and is found, together with
KRT8, in simple epithelia where they heterodimerise to
form the intermediate filaments. They influence the 3-D
formation of cell-cell or cell-substrate contacts in embry-
onic visceral endoderm [39-41]. Stanton and Green [42]
reported in mouse embryos a progressive rise for both
KRTs from the 2-cell to the blastocyst stage, paralleling the
development of the TE. Targeted deletion of KRT18 in the
mouse leads to trophoblast fragility and early embryonic
lethality [43]. Other cytoskeletal proteins such as α-cat-
enin, β-catenin, occludin, zonula occludens protein-1 and
connexin43 are also expressed at the cell-cell contact sides
of the TE cells [44], suggesting a co-localisation with
KRT18.
FN1 was found to be significantly higher expressed in
blastocysts compared to the earlier stages, and this differ-
ence was even 3.5× higher in the in vivo produced embryos
compared to the in vitro produced ones. FN1 protein was
predominantly expressed in the ICM and formed filamen-
tous structures between the TE and the ICM. The differen-
tial expression of FN1  in blastocyst stage embryos of
several mammalian species, including bovine, has previ-
ously been reported by other authors [4,22,45-47] and
this gene has been associated with blastocyst formation. It
is an adhesive extracellular matrix component and per-
KRT18 and MYL6 expression in in vitro produced bovine blas- tocysts Figure 3
KRT18 and MYL6 expression in in vitro produced 
bovine blastocysts. A) Image of the surface of a bovine 
blastocyst day 8 p.i.labelled for KRT18. The nuclei were 
stained with propidium iodide. KRT18 was expressed at the 
cell-cell contact sites of the trophectoderm cells. B) Image of 
a midplane section through a bovine blastocyst day 8 p.i. 
labelled with antibodies for MYL6. The nuclei were stained 
with propidium iodide. MYL6 proteins were located in the 
trophectoderm cells surrounding the blastocoel cavity.BMC Developmental Biology 2007, 7:64 http://www.biomedcentral.com/1471-213X/7/64
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forms a vital role during cell proliferation, cell adhesion
and cell mobility. It exists as a homodimer and is com-
posed of several domains such as a heparin binding
domain, a fibrin binding domain, a collagen binding
domain and a cell recognition domain. This provides FN1
with the opportunity to interact with and bind to several
ligands such as cells, heparin, fibrin, collagen, immu-
noglobulins and DNA [48]. Because events such as cell
proliferation, cell adhesion and cell mobility are essential
during early embryogenesis, FN1 does qualify as an
important participant during this phase of embryo devel-
opment. Besides, Aplin and colleagues [46] reported that
FN1 acts as a bridging ligand between the collagen matrix
and integrins at the cytotrophoblast surface, mediating
anchorage and/or migratory activity in the process of
implantation. The vital importance of FN1 for normal
embryo development has been demonstrated convinc-
ingly since mouse embryos lacking this protein die shortly
after gastrulation from mesodermal defects [49]. The sig-
nificant difference in FN1 mRNA expression levels which
we noticed between in vivo and in vitro produced bovine
embryos has also been reported by Mohan and colleagues
[10]. Lower RNA levels exhibited by in vitro produced
embryos may be responsible for the poor quality of these
embryos compared to their in vivo counterparts.
Myosin light chains associate with the motor protein
myosin and are believed to play a role in the regulation of
its actin-based ATPase activity. RNA levels of MYL6, the
smooth muscle isoform of myosin light chain, were sig-
nificantly higher at the blastocyst stage compared to the
earlier stages. No significant differences were seen
between in vivo and in vitro produced embryos. MYL6 is
involved in the cytoskeletal organisation [50] which is in
agreement with the observed protein expression in the TE
cells surrounding the blastocoel cavity. The expression of
MYL6 proteins around the blastocoel may also contribute
to the statement of Niimura [51] who inferred that con-
tractions in mouse blastocysts occur by activation of
myosin light chain kinase resulting in the phosphoryla-
tion of myosin light chains and causing the efflux of blas-
tocoelic fluid.
ATP1B3  shows a significant difference in RNA levels
between the 2/8-cell stage and the blastocyst stage of in
vitro produced embryos, but remarkably this difference is
negligible for in vivo produced embryos. The Na/K ATPase
consists of a catalytic α subunit and a noncatalytic, glyco-
sylated β subunit, each encoded by multigene families
[52]. The β subunit is required for structural and func-
tional maturation of the α subunit [53]. Blastocyst forma-
tion involves the establishment of a transtrophectoderm
ion gradient mediated by the Na/K ATPase which pumps
water through water channels called aquaporins [28].
Accumulation of fluid in the blastocoel is essential for dif-
ferentiation of the ICM and TE cell types [54]. The gene
expression patterns of several Na/K ATPase subunits have
been reported previously in mouse [55] and bovine [56],
and Adjaye and colleagues [57] identified ATP1B3 as a
marker specific for the TE in human blastocysts using a
cDNA microarray but as far as we know, this is the first
study in which the RNA expression levels of ATP1B3 in
bovine embryos are described. The higher ATP1B3 RNA
levels in in vitro produced blastocysts might be an expla-
nation for the faster blastulation of in vitro produced
embryos compared to in vivo produced ones. Van Soom
and colleagues [58] have demonstrated that in vivo moru-
lae display a more firm and prolonged compaction and
that they start blastulation at a later embryonic age and
cell number, moreover the addition of serum to the cul-
ture medium seemed to enhance blastocyst development
[59]. In vivo morulae develop more gradually to the blast-
ocyst stage and this might go together with a slower rise in
ATP1B3 expression. Another explanation for the higher
ATP1B3 expression in vitro might be a compensation for
the lower expression of another NA/K ATPase subunit or
another functional analogue, but this was not further
investigated.
The differences between the blastocysts and the 2- and 8-
cell stage embryos for FTH1 were smaller but significant
and no differences were observed between in vivo and in
vitro produced embryos. FTH1 has an important role in
the control of intracellular iron distribution and the con-
stitution of long term iron stores. The ferroxidase activity
associated with the H subunit is necessary for iron uptake
by the ferritin molecule. FTH1-/- mice embryos die
between 3.5 and 9.5 days of development [60] demon-
strating that the ferritin H subunit is indispensable for
embryonic development. FTH1 was also present in the
human blastocyst SSH library as reported by Morozov et
al. [61].
The mRNA levels for ATP6V0B,  HINT1,  RPL10  and
SLC25A5 were higher at the blastocyst stage compared to
the earlier stages for in vitro produced embryos, but no sig-
nificant differences existed between the in vivo produced
8-cell and in vivo produced blastocyst embryos. The qPCR
results of those genes for in vitro produced embryos con-
firmed the results of the subtractive cDNA library.
The RNA expression patterns of the remaining genes
(ACTN1, COPE and EEF1A1) were not in agreement with
the subtractive cDNA cloning results. Those genes were
abundant at an equal amount or higher at the earlier
stages. Those false positives prove the requirement for the
verification of the subtractive cDNA outcome and are in
agreement with the reported 30% false positives obtained
by subtractive cDNA cloning in previous studies [10]. The
significantly higher RNA levels in vivo produced 8-cellBMC Developmental Biology 2007, 7:64 http://www.biomedcentral.com/1471-213X/7/64
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embryos for COPE but also for EEF1A1 is an important
observation. COPE is a subunit of the coatomer protein
complex and is involved in the retrograde Golgi-to-ER
transport of dilysine-tagged proteins, whereas EEF1A1 is
responsible for the enzymatic delivery of aminoacyl
tRNAs to the ribosome. Both genes are involved in protein
synthesis. Around the 8–16 cell stage the embryonic
genome becomes active, resulting in the synthesis of
embryonic proteins. The lower expression of genes
involved in protein synthesis (COPE, EEF1A1 and RPL10)
in in vitro 8-cell embryos might indicate that the embry-
onic protein synthesis is affected or delayed in in vitro
embryos.
Differences in gene expression between in vivo and in vitro
produced embryos reflect the effects of the in vitro culture
system on the transcriptional activity [11]. Preimplanta-
tion embryos are capable of developing in a wide range of
culture conditions. However, this adaptation of the
embryo to suboptimal conditions may result in a lower
embryo quality. It will be a challenge for the future to
determine the importance of the affected genes for the
process of embryo development and to change the culture
conditions in vitro in order to induce the expression of
those genes to levels identical to those under in vivo con-
ditions, and in this way improve the quality of the
embryo.
Conclusion
The results of this study add to the knowledge of the proc-
ess of bovine blastocyst formation. Several genes were
identified as candidate markers involved in blastocyst for-
mation. The fact that some of those candidate genes were
differentially expressed between in vivo and in vitro pro-
duced embryos confirms the belief that culture conditions
influence embryonic gene expression. Further functional
analyses of these candidate genes may help to optimise in
vitro embryo culture systems in order to improve the qual-
ity of in vitro produced bovine embryo.
Methods
In vitro embryo production
Bovine embryos were produced in vitro as described by
Yuan and colleagues [62]. Briefly, bovine oocytes were
aspirated from ovaries collected at a local slaughterhouse.
Immature cumulus-oocyte complexes were selected from
follicular fluid, washed three times in HEPES-TALP and
matured for 22 to 26 hr in groups of 100 in 500 µl matu-
ration medium at 39°C in a humidified 5% CO2 incuba-
tor. After maturation, the oocytes were inseminated with
frozen-thawed sperm from one bull (1 × 106 spermato-
zoa/ml). After 20 hr the cumulus cells and spermatozoa
were mechanically removed from the presumptive
zygotes, which were placed in groups of 25 in 50 µl drop-
lets of synthetic oviduct fluid supplemented with 5% fetal
calf serum and cultured up to the desired stages at 39°C
in 5% CO2, 5% O2 and 90% N2. The embryos were col-
lected at the indicative time period after fertilisation: 2-
cell (24–28 hr p.i.), 8-cell (48–52 hr p.i.), blastocyst (day
8). All embryos were washed three times in PBS, pooled
and frozen at -80°C until RNA extraction.
In vivo embryo production
The  in vivo embryo production protocol has been
approved by the local ethical committee and was done
after superovulation and artificial insemination of 4 Hol-
stein cows for the collection of 2-cell and 8-cell embryos
and 2 Holstein heifers for the collection of blastocysts.
Oestrus cycles of the donor cows and heifers were syn-
chronized by two intramuscular injections (on day 1 and
on day 12) with 526 mg of cloprostenol (Estrumate® –
Shering-Plough, Belgium), followed by oestrus detection
2 days later. Donor cows were intramuscularly injected
with 8 equal doses of Stimufol® (Université de Liège, Bel-
gium) (500 µg porcine FSH-100 µg porcine LH) over 4
days, where as heifers received a lower total dosis of
Stimufol® (Université de Liège, Belgium) (250 µg porcine
FSH-50 µg porcine LH) in 8 decreasing doses over 4 days.
Stimufol administration was started at day 10 in the cows
and at day 11 and 12 in the heifers in order to group the
embryo collections. To induce luteolysis, 789 mg clopros-
tenol (Estrumate®  – Shering-Plough, Belgium) was
injected along with the 5th injection of pFSH/pLH. All
donors were checked for oestrus 48 h after the cloproste-
nol injection and artificially (AI) inseminated twice with
two straws of semen of a bull of established fertility on 12
and 24 hr after the onset of the oestrus. The same bull was
used for in vivo and in vitro insemination. The 2-cell and
8-cell embryos were recovered 36 hours respectively 84
hours after AI. After collection of the reproductive tract at
the slaughterhouse, the fallopian tube and the uterus were
both flushed with approximately 250 ml PBS supple-
mented with 2% FCS. Blastocysts were recovered by non-
surgical uterine flushing on day 7 and 8 after AI. After epi-
dural anaesthesia with 5 ml Procaine HCL 4%® (procaine-
hydrochloride, VMD, Belgium), each horn was flushed
with 0.5 l of PBS.
All in vivo embryos were washed four times in Hepes-Talp
and subsequently three times in PBS before freezing at -
80°C.
Construction of the SSH library
mRNA extraction, cDNA synthesis and amplification
Poly(A)+ RNA was isolated from a pool of 40 IVP blasto-
cysts (day 8) as a tester population and a pool of 40 IVP
embryos at the 2-cell and 40 at the 8-cell stage as a driver
population, using the Oligotex Direct Mini Kit (Qiagen,
the Netherlands) according to the manufacturer's instruc-
tions.BMC Developmental Biology 2007, 7:64 http://www.biomedcentral.com/1471-213X/7/64
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Due to the small amounts of mRNA extracted from bovine
embryos, both tester and driver mRNA were reverse tran-
scribed and amplified using the SMART PCR cDNA syn-
thesis Kit (Takara Bio Inc., France). This kit is optimised
for the amplification of cDNA without altering the origi-
nal expression ratios [63,64] and is widely used in combi-
nation with the subtractive hybridisation procedure to
study gene expression during embryo development
[4,10,30,65,66].
Suppression Subtractive Hybridisation
The SSH was performed with the PCR-Select cDNA Sub-
traction Kit (Takara Bio Inc., France) following the manu-
facturer's instructions. Amplified double-stranded cDNA
from the tester and driver was RsaI digested, and 2 differ-
ent adaptors were ligated to 2 fractions of the tester popu-
lation. A first hybridisation was performed with an excess
of driver cDNA, followed by a second hybridisation
between the mixed tester fractions in the presence of an
excess driver. After the second hybridisation, tester cDNA
was subjected to two rounds of PCR to enrich the tester
specific cDNA fragments. The amplified products were
cloned into the pCR 2.1 vector (Invitrogen, Belgium) and
transformed into competent DH5α E. coli cells (Invitro-
gen, Belgium).
Clones were randomly picked, the DNA-inserts were
sequenced (Thermo Sequenase Primer Cycle Sequencing
Kit, Amersham Bioscience, the Netherlands) with the ALF
Express sequencer (Amersham Bioscience, the Nether-
lands) and identified using the BLAST algorithm [67].
Quantification of specific transcripts by real-time PCR
RNA extraction and cDNA amplification
For the quantification of the mRNA expression levels of
12 genes obtained by SSH, total RNA was isolated from 3
to 6 in vivo and in vitro produced single embryos per devel-
opmental stage (2-cell, 8-cell and blastocyst) using the
PicoPure RNA Isolation Kit (Arcturus, USA) according to
the manufacturer's instructions. An in solution DNase
digestion followed by an RT minus control was performed
as described by Goossens and colleagues [25]. The first-
strand cDNA synthesis and linear amplification were
done using the WT-Ovation RNA Amplification system
(NuGEN, The Netherlands) as described in the manufac-
turer's instructions. After the RT reaction and the linear
amplification step, the cDNA was 50 times diluted in 10
mM Tris HCl pH 8.0.
Primer design
Sequence-specific primers were designed for 12 identified
genes by the Primer 3 software [68] (Table 2). The specif-
icity of the primers was tested using a BLAST analysis
against the genomic NCBI database. PCR amplicons were
characterised using Mfold [69] in order to account for any
secondary structures which might influence the PCR effi-
ciency. The PCR products were cloned (pCR 2.1 vector,
Invitrogen, Belgium) and sequenced for verification
(Thermo Sequenase Primer Cycle Sequencing Kit, Amer-
sham Bioscience, the Netherlands) with a ALF Express
sequencer (Amersham Bioscience, the Netherlands).
Real-time PCR reactions
All PCR reactions were performed in a 15 µl reaction vol-
ume on the iCycler iQ Real-Time PCR Detection System
(Bio-Rad, Belgium) using the Platinum SYBR Green qPCR
SuperMix-UDG (Invitrogen, Belgium) and 200 nM of
each specific primer. The PCR program consisted of an ini-
tial UDG incubation step at 50°C for 2 minutes and an
initial denaturation step at 95°C for 3 minutes to activate
the Taq DNA polymerase, followed by 45 cycles of dena-
turation at 95°C for 20 seconds and a combined primer
annealing/extension at the specific annealing temperature
for 40 seconds during which fluorescence was measured.
A melt curve was produced to confirm a single gene-spe-
cific peak and to detect primer-dimer formation by heat-
ing the samples from 70 to 95°C in 0.5°C increments
with a dwell time at each temperature of 10 seconds while
continuously monitoring the fluorescence. PCR efficien-
cies were calculated using a relative standard curve derived
from a pooled cDNA mixture (a 10-fold dilution series
with five measuring points). Each reaction was run in
duplicate in the same run, whereby a no-template control
was included.
The geometric mean of three reference genes, YWHAZ,
GAPD and SDHA, was used to calculate an accurate nor-
malisation factor as described by Goossens and colleagues
[25]. The mean quantity of each transcript (raw data) was
divided by the respective normalisation factor to obtain a
normalised value for each transcript. The sample with the
lowest value was assigned the value 1. The normalised tar-
get values were divided by the calibrator normalised target
values to generate the relative expression levels.
The normalised gene expression levels were analysed by
calculating 95% confidence intervals after logarithmic
transformations, whereby non-overlapping intervals
denote significant differences at the 0.05 level.
Immunofluorescent labelling
Pools of 10 embryos per developmental stage (2–4 cell
(24–28 hr p.i.), 5–8 cell (48–52 hr p.i.), morula day 5 p.i.,
morula day 7 p.i., blastocyst day 7 p.i. and hatched blast-
ocyst day 8 p.i) were selected from the culture media,
washed 3 times in PBS and fixed with 4% paraformalde-
hyde (Sigma, Belgium) in PBS for 1 hour at 4°C.
After washing in polyvinyl pyrrolidone (PVP; 1 mg PVP/
ml PBS), the embryos were permeabilized with 0.5% Tri-BMC Developmental Biology 2007, 7:64 http://www.biomedcentral.com/1471-213X/7/64
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ton X-100 (Sigma, Belgium) in PBS for 30 min at room
temperature. Non-specific binding sites were blocked
with 10% goat serum in PVP for 30 min. After 3 washes in
PVP the embryos were incubated with the mouse primary
antibodies against FN1, KRT18 and MYL6 respectively
(Table 3) for 2 hours at 37°C, washed again 3 times in
PVP and then incubated with FITC-labeled goat-anti-
mouse secondary antibodies (Molecular Probes, Invitro-
gen, Belgium) for 1 hour at 37°C in the dark.
The nuclei were stained with 0.5% propidium iodide (PI;
Molecular Probes, Invitrogen, Belgium) for 30 min at
room temperature. After 2 washes in PVP the embryos
were mounted in a drop of glycerol with 1,4-diazabicyclo
(2.2.2) octane (25 mg/ml) on slides with vaseline bridges.
Negative (by replacing the primary antibody with goat
serum) and double negative controls (only PI staining)
were performed simultaneously to check for non-specific
binding of the secondary antibody and for auto-fluores-
cence. A monolayer of cultured cumulus cells was used as
a positive control. The results of the control experiments
were supplemented in additional file 1.
Samples were examined by fluorescence microscopy
(Leica DMR, Van Hopplynus, Belgium) and by confocal
laser scanning microscopy (Leica TCS SP2 laser scanning
spectral confocal system linked to a Leica DM IRB inverted
microscope, Leica Microsystems GmbH, Germany). A
krypton-argon ion laser was used for the simultaneous
excitation of fluorescence for proteins and PI for DNA. All
the labelling experiments were performed in duplicate.
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